drugset / Trial / NCT07543796
Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase IIa, multicenter ,randomized, double-blind, Double-Dummy, Active- and placebo-controlled study designed to evaluate the efficacy, safety and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty
Timeline
- Start
- 2026-03-18
- Primary completion
- 2026-06-27
- Completion
- 2026-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | Oral |
| Subject | TRD205 | Unknown | 200 mg | Oral |
| Subject | TRD205 | Unknown | 400 mg | Oral |
| Subject | TRD205 | Unknown | 600 mg | Oral |
Indications
No indication recorded.